Grant: Discovery Grants Program - Individual
The University of British Columbia
$99,000.00
Advanced Materials and Portable Devices Toward Digital Assays, Point-of-Care Diagnostics, and Enhanced Bioanalyses
EF 2024-25
Résumé
The detection and quantification of molecular markers of health, disease, and infection is essential for health care, personalized medicine, and public health. In practice, these measurements require specialized facilities with large and expensive equipment and specially trained personnel. This requirement creates substantial inequity in access and quality of health care, both between different countries and between different communities or social groups within a country. Advances in both policies and technologies are needed to address these problems. Molecular diagnostic technology that is easy to use, portable, and low cost (a.k.a. point-of-care diagnostics) will be essential for realizing quality health care as a globally accessible human right.
Here, we propose new materials, methods, and devices for molecular diagnostics, alongside multidisciplinary training of three levels of HQP. This research will leverage our leadership in developing and implementing fluorescent nanoparticle (NP) materials to enable bioanalysis with smartphone-based devices. Our aims are to address unmet needs for point-of-care diagnostics, particularly with respect to key functional requirements: high sensitivity, multiplexing (i.e. parallel detection of multiple biomarkers), mix-and-measure capability (i.e. little or no user actions), quantitation without user calibration, sustainability, and optimized material properties.
Some of the proposed research will leverage super-NP assemblies of quantum dots (super-QDs) that exhibit ultra-bright fluorescence, robust stability, and specific binding as immunoconjugates. We will develop mix-and-measure, calibration-free digital assays for protein biomarker and virus detection--without the compartmentalization, enzymatic amplification, or high-technology requirements of current methods. This assay and other assays will be ported from laboratory instruments to smartphone-based devices capable of total internal reflection fluorescence (TIRF), and benefit from new low-valent, clickable, and biofluid-compatible super-QDs. The methodology will also be extended to super-NP assemblies of other materials for enhancement of their special size-limited properties: magnetic NPs, silicon nanocrystals, and gold NPs. The new super-NPs will provide better sustainability and new opportunities and for fluorescence- and Raman-based bioanalyses. With the goal of reducing environmental impact, other research will design and optimize next-generation fluorescent NPs for future digital assays, smartphone-based diagnostics, and other applications in bioanalysis and imaging. These innovative materials will be derived from single dextran chains and aggregation-induced emission dyes, and from scaffolded J-aggregate nanoparticles with spectral properties tailored by energy transfer.
Overall, the research explores new, impactful ideas for functional materials, assay methods, and devices with transformative potential for future molecular diagnostics.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2024-06162
Name nom
Algar, W Russ
Department département
Chemistry - Chemistry
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
99000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Advanced Materials and Portable Devices Toward Digital Assays, Point-of-Care Diagnostics, and Enhanced Bioanalyses
Keywords
point-of-care diagnostics; immunoassays; digital assays; fluorescence; quantum dots; nanoparticles; portable devices; single-particle imaging; microscopy
Application summary
The detection and quantification of molecular markers of health, disease, and infection is essential for health care, personalized medicine, and public health. In practice, these measurements require specialized facilities with large and expensive equipment and specially trained personnel. This requirement creates substantial inequity in access and quality of health care, both between different countries and between different communities or social groups within a country. Advances in both policies and technologies are needed to address these problems. Molecular diagnostic technology that is easy to use, portable, and low cost (a.k.a. point-of-care diagnostics) will be essential for realizing quality health care as a globally accessible human right.
Here, we propose new materials, methods, and devices for molecular diagnostics, alongside multidisciplinary training of three levels of HQP. This research will leverage our leadership in developing and implementing fluorescent nanoparticle (NP) materials to enable bioanalysis with smartphone-based devices. Our aims are to address unmet needs for point-of-care diagnostics, particularly with respect to key functional requirements: high sensitivity, multiplexing (i.e. parallel detection of multiple biomarkers), mix-and-measure capability (i.e. little or no user actions), quantitation without user calibration, sustainability, and optimized material properties.
Some of the proposed research will leverage super-NP assemblies of quantum dots (super-QDs) that exhibit ultra-bright fluorescence, robust stability, and specific binding as immunoconjugates. We will develop mix-and-measure, calibration-free digital assays for protein biomarker and virus detection--without the compartmentalization, enzymatic amplification, or high-technology requirements of current methods. This assay and other assays will be ported from laboratory instruments to smartphone-based devices capable of total internal reflection fluorescence (TIRF), and benefit from new low-valent, clickable, and biofluid-compatible super-QDs. The methodology will also be extended to super-NP assemblies of other materials for enhancement of their special size-limited properties: magnetic NPs, silicon nanocrystals, and gold NPs. The new super-NPs will provide better sustainability and new opportunities and for fluorescence- and Raman-based bioanalyses. With the goal of reducing environmental impact, other research will design and optimize next-generation fluorescent NPs for future digital assays, smartphone-based diagnostics, and other applications in bioanalysis and imaging. These innovative materials will be derived from single dextran chains and aggregation-induced emission dyes, and from scaffolded J-aggregate nanoparticles with spectral properties tailored by energy transfer.
Overall, the research explores new, impactful ideas for functional materials, assay methods, and devices with transformative potential for future molecular diagnostics.